Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia

4Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study was designed to investigate whether a correlation exists between amplification of the human telomerase gene (human telomerase RNA component [TERC]) and high-risk human papillomavirus (HR-HPV) infection in 101 women with cervical intra-epithelial neoplasia (CIN). Eight patients (7.9%) had CIN 1, 24 (23.8%) had CIN 2 and 69 (68.3%) had CIN 3. TERC was amplified in 31.7% of all CIN patients. The difference in frequency of TERC amplification between patients with low-grade CIN (CIN 1) and those with high-grade CIN (CIN 2 and CIN 3) was not significant. HR-HPV infection was detected in 88.1% of all CIN cases and was significantly more frequent in patients with CIN 2 and CIN 3 than in patients with CIN 1. There was no significant difference in the frequency of HR-HPV infection between groups of patients with and without TERC amplification. In conclusion, this study found no correlation between TERC amplification and HR-HPV infection in patients with CIN. Copyright © 2009 Field House Publishing LLP.

Cite

CITATION STYLE

APA

Takač, I., Arko, D., Kodrič, T., Poljak, M., Zagorac, A., Erjavec-Škerget, A., & Kokalj-Vokač, N. (2009). Human telomerase gene amplification and high-risk human papillomavirus infection in women with cervical intra-epithelial neoplasia. Journal of International Medical Research, 37(5), 1588–1595. https://doi.org/10.1177/147323000903700537

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free